Physician profile
Randy Everett
NPI 1285680306
$4,230.04
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $2,082 · 2021: $932 · 2022: $500 · 2023: $596 · 2024: $13.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.55 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,317.64 | 2020-2021 | |
| Astellas Pharma US INC | $406.98 | 2019-2023 | Myrbetriq |
| Janssen Biotech, INC. | $329.45 | 2021-2023 | Erleada |
| Myovant Sciences INC. | $195.13 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $118.68 | 2022-2023 | Provenge |
| Abbvie INC. | $117.85 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $111.32 | 2023 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $100.20 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $61.28 | 2021-2022 | |
| Pfizer INC. | $54.72 | 2021-2023 | |
| Axonics, INC. | $40.67 | 2023 | Bulkamid, Axonics |
| Teleflex LLC | $39.43 | 2021-2023 | Urolift |
| 180 Medical, INC. | $37.44 | 2021-2023 | Gentlecath Glide |
| Bayer Healthcare Pharmaceuticals INC. | $36.73 | 2021-2022 | |
| Allergan, INC. | $34.17 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $30.84 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $25.47 | 2023 | Bard Urinary Drainage Bag |
| Palette Life Sciences, INC. | $23.54 | 2021 | |
| Amgen INC. | $23.35 | 2022 | |
| Angiodynamics, INC. | $22.05 | 2022 | |
| Merck Sharp & Dohme LLC | $21.45 | 2023 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $18.08 | 2021 | |
| Blue Earth Diagnostics | $17.36 | 2019 | |
| Dentsply Ih INC. | $17.13 | 2021 | |
| Olympus America INC. | $16.50 | 2019 | |
| Ambu INC. | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.